Evidence map›Paper›PMID 33650525›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2021

Advances in pleural infection and malignancy.

Eihab O Bedawi, Julien Guinde, Najiib M Rahman, Philippe Astoul

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05759390 (Role of Ultrasound Elastography in Differentiation of Peripheral Lung Lesions), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05759390 completednot on this mapstarted 2022, after this paper: background citation

Role of Ultrasound Elastography in Differentiation of Peripheral Lung Lesions

TypeobservationalSponsorAssiut UniversityRan2022 to 2024Enrolled46ConditionsLung DiseasesArmsUltrasound elastography
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Benign vs. malignant pulmonary nodules: pleural adhesion risks and predictors.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Observational
  3. Management and prognosis of malignant pleural effusions managed with indwelling pleural catheters.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. DNase inhibits early biofilm formation inFrontiers in cellular and infection microbiology · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Eihab O BedawiOxford Pleural Unit, Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, UK.ORCID https://orcid.org/0000-0001-9196-3934
Julien GuindeDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, North University Hospital, Marseille, France.
Najiib M RahmanOxford Pleural Unit, Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, UK.
Philippe AstoulDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, North University Hospital, Marseille, France pastoul@ap-hm.fr.ORCID https://orcid.org/0000-0003-3988-1792
Aix-Marseille Université · FROxford University Hospitals NHS Trust · GBUniversity of Oxford · GB

Funding

Medical Research Council G1001128
6 · The paper itself

Abstract

Pleural infection and malignancy are among the most common causes of pleural disease and form the mainstay of pleural practice. There has been significant research and increase in scientific understanding in these areas in the past decade. With regard to pleural infection, the rising incidence remains worrying. An increased awareness allowing earlier diagnosis, earlier escalation of therapy and the use of validated risk stratification measures may improve outcomes. In pleural malignancy, research has enabled clinicians to streamline patient pathways with focus on reducing time to diagnosis, definitive management of malignant pleural effusion and achieving these with the minimum number of pleural interventions. Trials comparing treatment modalities of malignant pleural effusion continue to highlight the importance of patient choice in clinical decision-making. This article aims to summarise some of the most recent literature informing current practice in these two areas.

Indexed as

Pleural DiseasesPleural Effusion, MalignantPleural NeoplasmsThoracic Surgical ProceduresHumans

Identifiers

PMID33650525
PMCPMC9488125
OpenAlexW3119307099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.